Correlation Between Blueprint Medicines and Genmab AS
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Genmab AS, you can compare the effects of market volatilities on Blueprint Medicines and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Genmab AS.
Diversification Opportunities for Blueprint Medicines and Genmab AS
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Blueprint and Genmab is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Genmab AS go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Genmab AS
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 1.6 times more return on investment than Genmab AS. However, Blueprint Medicines is 1.6 times more volatile than Genmab AS. It trades about 0.23 of its potential returns per unit of risk. Genmab AS is currently generating about -0.22 per unit of risk. If you would invest 9,063 in Blueprint Medicines Corp on November 9, 2024 and sell it today you would earn a total of 1,899 from holding Blueprint Medicines Corp or generate 20.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Genmab AS
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Genmab AS |
Blueprint Medicines and Genmab AS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Genmab AS
The main advantage of trading using opposite Blueprint Medicines and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Genmab AS vs. Ascendis Pharma AS | Genmab AS vs. Apellis Pharmaceuticals | Genmab AS vs. Akero Therapeutics | Genmab AS vs. Blueprint Medicines Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |